期刊文献+

Increased liver markers are associated with higher risk of type 2 diabetes 被引量:8

Increased liver markers are associated with higher risk of type 2 diabetes
下载PDF
导出
摘要 AIM: To investigate the association between liver markers and the risk of type 2 diabetes(T2DM) and impaired fasting glucose(IFG).METHODS: A total of 8863 participants(3408 men and 5455 women) over 30 years of age were analyzed from the fifth Korean National Health and Nutrition Examination Survey(2010-2011). The associations of serum liver markers such as aspartate aminotransferase(AST), alanine aminotransferase(ALT), AST/ALT, and gamma-glutamyltransferase(GGT) with T2 DM and IFG were analyzed using logistic regression models. Participants were divided into sex-specific quartiles on the basis of liver markers.RESULTS: The prevalence of T2 DM and IFG were 11.3% and 18.3%. Increasing quartiles of ALT and GGT were positively and AST/ALT were negatively correlated with T2 DM and IFG. Analysis of the liver marker combinations showed that if any two or more markers were in the highest risk quartile, the risks of both T2 DM and IFG increased significantly. The risk was greatest when the highest ALT and GGT and lowest AST/ALT quartile were combined, with the riskof T2 DM at 3.21(95%CI: 1.829-5.622, P < 0.001) in men and 4.60(95%CI: 3.217-6.582, P < 0.001) in women. Men and women with the highest AST and ALT and lowest AST/ALT quartile had a 1.99 and 2.40 times increased risk of IFG.CONCLUSION: Higher levels of GGT and ALT and lower AST/ALT within the physiological range are independent, additive risk factors of T2 DM and IFG. AIM: To investigate the association between liver markers and the risk of type 2 diabetes(T2DM) and impaired fasting glucose(IFG).METHODS: A total of 8863 participants(3408 men and 5455 women) over 30 years of age were analyzed from the fifth Korean National Health and Nutrition Examination Survey(2010-2011). The associations of serum liver markers such as aspartate aminotransferase(AST), alanine aminotransferase(ALT), AST/ALT, and gamma-glutamyltransferase(GGT) with T2 DM and IFG were analyzed using logistic regression models. Participants were divided into sex-specific quartiles on the basis of liver markers.RESULTS: The prevalence of T2 DM and IFG were 11.3% and 18.3%. Increasing quartiles of ALT and GGT were positively and AST/ALT were negatively correlated with T2 DM and IFG. Analysis of the liver marker combinations showed that if any two or more markers were in the highest risk quartile, the risks of both T2 DM and IFG increased significantly. The risk was greatest when the highest ALT and GGT and lowest AST/ALT quartile were combined, with the riskof T2 DM at 3.21(95%CI: 1.829-5.622, P < 0.001) in men and 4.60(95%CI: 3.217-6.582, P < 0.001) in women. Men and women with the highest AST and ALT and lowest AST/ALT quartile had a 1.99 and 2.40 times increased risk of IFG.CONCLUSION: Higher levels of GGT and ALT and lower AST/ALT within the physiological range are independent, additive risk factors of T2 DM and IFG.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第24期7478-7487,共10页 世界胃肠病学杂志(英文版)
基金 the Division of Chronic Disease Surveillance of the Korean Center for Disease Control and Prevention who conducted the national survey and everyone who contributed to this project
关键词 Type 2 diabetes mellitus LIVER MARKERS Impaired fasting glucose Gamma-glutamyl TRANSFERASE ASPARTATE AMINOTRANSFERASE ALANINE AMINOTRANSFERASE Type 2 diabetes mellitus Liver markers Impaired fasting glucose Gamma-glutamyl transferase Aspartate aminotransferase Alanine aminotransferase
  • 相关文献

参考文献39

  • 1Onat A, Can Grnek E, G, Ayhan E, Do-an Y. Serumγ-glutamyltransferase: independent predictor of risk of diabetes,hypertension, metabolic syndrome, and coronary disease. Obesity(Silver Spring) 2012; 20: 842-848 [PMID: 21633402 DOI:10.1038/oby.2011.136].
  • 2Grundy SM. Gamma-glutamyl transferase: another biomarker formetabolic syndrome and cardiovascular risk. Arterioscler ThrombVasc Biol 2007; 27: 4-7 [PMID: 17185620 DOI: 10.1161/01.ATV.0000253905.13219.4b].
  • 3Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase,atherosclerosis, and cardiovascular disease: triggering oxidativestress within the plaque. Circulation 2005; 112: 2078-2080 [PMID:16203922 DOI: 10.1161/CIRCULATIONAHA.105.571919].
  • 4Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M,Blomhoff R, Jacobs DR. Gamma-glutamyltransferase and diabetes--a 4 year follow-up study. Diabetologia 2003; 46: 359-364 [PMID:12687334 DOI: 10.1007/s00125-003-1036-5].
  • 5Gautier A, Balkau B, Lange C, Tichet J, Bonnet F. Risk factorsfor incident type 2 diabetes in individuals with a BMI of & lt;27 kg/m2: the role of gamma-glutamyltransferase. Data froman Epidemiological Study on the Insulin Resistance Syndrome(DESIR). Diabetologia 2010; 53: 247-253 [PMID: 19936701 DOI:10.1007/s00125-009-1602-6].
  • 6André P, Balkau B, Vol S, Charles MA, Eschwège E. Gammaglutamyltransferaseactivity and development of the metabolicsyndrome (International Diabetes Federation Definition) in middleagedmen and women: Data from the Epidemiological Study onthe Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care2007; 30: 2355-2361 [PMID: 17586745 DOI: 10.2337/dc07-0440].
  • 7Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyltransferaseand risk of metabolic syndrome and type 2 diabetes inmiddle-aged Japanese men. Diabetes Care 2004; 27: 1427-1432[PMID: 15161799].
  • 8Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepaticenzymes, the metabolic syndrome, and the risk of type 2 diabetes inolder men. Diabetes Care 2005; 28: 2913-2918 [PMID: 16306554].
  • 9André P, Balkau B, Born C, Royer B, Wilpart E, Charles MA,Eschwège E. Hepatic markers and development of type 2 diabetesin middle aged men and women: a three-year follow-up study.The D.E.S.I.R. Study (Data from an Epidemiological Study on theInsulin Resistance syndrome). Diabetes Metab 2005; 31: 542-550[PMID: 16357802 DOI: 10.1016/s1262-3636(07)70229-x].
  • 10Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE,Bogardus C, Tataranni PA. High alanine aminotransferase isassociated with decreased hepatic insulin sensitivity and predictsthe development of type 2 diabetes. Diabetes 2002; 51: 1889-1895[PMID: 12031978].

同被引文献20

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部